Headspace solid-phase microextraction and gas chromatography–mass spectrometry of volatile components of Chrysanthemum morifolium Ramat

Purpose: To extract and analyze the volatile components of Chrysanthemum morifolium Ramat. 'huaiju' by headspace solid-phase microextraction (HS-SPME) and gas chromatography–mass spectrometry (GC–MS).Methods: Volatile components were extracted by HS-SPME and identified by GC–MS. The relative contents of the components were determined by area normalization.Results: The enhanced SPME conditions of C. morifolium involved sample extraction using a 65 μm polydimethylsiloxane/divinylbenzene extraction fiber after balancing for 40 min at 80 °C. A total of 48 components of the essential oil were identified. The major constituents are 2,6,6-trimethylbicyclo[3.1.1]hept-2-en-4-ol, acetate (15.90 %), 4,6,6-trimethyl-bicyclo[3.1.1]hept-3-en-2-one (14.86 %), 2,7,7-trimethyl-bicyclo[3.1.1]hept-2-en-6-one (13.08 %), and cyclohexene,3-(1,5-dimethyl-4-hexenyl)-6- methylene (5.97 %).Conclusion: HS-SPME and GC–MS are convenient, rapid, and reliable approaches for analyzing the volatile components of C. morifolium.Keywords: Chrysanthemum morifolium Ramat., Headspace Solid-phase Microextraction, Gas Chromatography–Mass Spectrometry, Volatile componen

Chidamide and Decitabine in Combination with a HAG Priming Regimen for Acute Myeloid Leukemia with TP53 Mutation

We analyzed the treatment effects of chidamide and decitabine in combination with a HAG (homoharringtonine, cytarabine, G-CSF) priming regimen (CDHAG) in acute myeloid leukemia (AML) patients with TP53 mutation. Seven TP53 mutated AML patients were treated with CDHAG. The treatment effects were assessed using hemogram detection and bone marrow aspirate. The possible side effects were evaluated based on both hematological and non-hematological toxicity. Four of the seven patients were classified as having achieved complete remission after CDHAG treatment; one patient was considered to have achieved partial remission, and the remaining two patients were considered in non-remission. The overall response rate (ORR) to CDHAG was 71.4%. Regarding the side effects, the hematological toxicity level of the seven patients ranged from level III to level IV, and infections that occurred at lung, blood, and skin were recorded. Nausea, vomiting, liver injury, and kidney injury were also detected. However, all side effects were attenuated by proper management. The CDHAG regimen clearly improved the ORR (71.4%) of TP53-mutated AML patients, with no severe side effects

A snoRNA modulates mRNA 3' end processing and regulates the expression of a subset of mRNAs.

mRNA 3' end processing is an essential step in gene expression. It is well established that canonical eukaryotic pre-mRNA 3' processing is carried out within a macromolecular machinery consisting of dozens of trans-acting proteins. However, it is unknown whether RNAs play any role in this process. Unexpectedly, we found that a subset of small nucleolar RNAs (snoRNAs) are associated with the mammalian mRNA 3' processing complex. These snoRNAs primarily interact with Fip1, a component of cleavage and polyadenylation specificity factor (CPSF). We have functionally characterized one of these snoRNAs and our results demonstrated that the U/A-rich SNORD50A inhibits mRNA 3' processing by blocking the Fip1-poly(A) site (PAS) interaction. Consistently, SNORD50A depletion altered the Fip1-RNA interaction landscape and changed the alternative polyadenylation (APA) profiles and/or transcript levels of a subset of genes. Taken together, our data revealed a novel function for snoRNAs and provided the first evidence that non-coding RNAs may play an important role in regulating mRNA 3' processing

2-[(E)-2-(Benzyl­idene­amino)­eth­yl]-3′,6′-bis­(diethyl­amino)­spiro­[isoindoline-1,9′-xanthen]-3-one

In the title compound, C37H40N4O2, the xanthene and spiro­lactam rings are almost planar, with r.m.s. deviations from the mean planes of 0.223 (2) and 0.057 (2) Å, respectively, and form a dihedral angle of 85.76 (3)°. The dihedral angle between the xanthene mean plane and the benzene ring is 87.16 (5)°. One of the two ethyl groups of one of the diethyl­amino groups is disordered over two sets of sites [0.76 (1):0.24 (1)]